Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2009 2
2010 1
2011 2
2013 4
2014 4
2015 3
2016 2
2017 1
2018 6
2019 2
2020 7
2021 2
2022 1
2023 5
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Zinc Fingers.
Isernia C, Malgieri G, Russo L, D'Abrosca G, Baglivo I, Pedone PV, Fattorusso R. Isernia C, et al. Among authors: baglivo i. Met Ions Life Sci. 2020 Mar 23;20:/books/9783110589757/9783110589757-018/9783110589757-018.xml. doi: 10.1515/9783110589757-018. Met Ions Life Sci. 2020. PMID: 32851833 Free article.
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells.
Sobinoff AP, Di Maro S, Low RRJ, Benedetti R, Tomassi S, D'Aniello A, Russo R, Baglivo I, Chianese U, Pedone PV, Chambery A, Cesare AJ, Altucci L, Pickett HA, Cosconati S. Sobinoff AP, et al. Among authors: baglivo i. Cell Chem Biol. 2023 Dec 21;30(12):1652-1665.e6. doi: 10.1016/j.chembiol.2023.11.008. Epub 2023 Dec 7. Cell Chem Biol. 2023. PMID: 38065101 Free article.
The last step to achieve barrier damage control.
Baglivo I, Colantuono S, Lumaca A, Papa A, Gasbarrini A, Caruso C. Baglivo I, et al. Front Immunol. 2024 Feb 13;15:1354556. doi: 10.3389/fimmu.2024.1354556. eCollection 2024. Front Immunol. 2024. PMID: 38415254 Free PMC article.
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
Caruso C, Ciasca G, Baglivo I, Di Santo R, Gasbarrini A, Firinu D, Bagnasco D, Passalacqua G, Schiappoli M, Caminati M, Canonica GW, Heffler E, Crimi C, Intravaia R, Basile V, Marino M, Colantuono S, Del Giacco S. Caruso C, et al. Among authors: baglivo i. Allergy. 2024 Sep;79(9):2414-2422. doi: 10.1111/all.16082. Epub 2024 Feb 29. Allergy. 2024. PMID: 38425088
47 results